Flow cytometry testing technology services is a technology that measures the biological, physical and chemical characteristics of individual cells or organelles in a liquid system, and quantitatively analyzes and sorts the required cells or organelles according to these characteristics. It is a technology that can detect various characteristics of cells or biological particles, used to understand the mean and distribution of cell populations, and can also sort cells of interest for further culture research on the cells.
The global market for Flow Cytometry Testing Technology Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Flow Cytometry (FCM) is a high-tech technology developed in the 1970s. It is a modern cell analysis technology that can detect multiple parameters of a single particle quickly, accurately and objectively. It integrates computer technology, laser technology, fluid mechanics, cytochemistry, and cellular immunology, and has the function of analyzing and sorting cells. It can not only measure the characteristics of cell size and internal particles, but also detect cell surface and cytoplasmic antigens, intracellular DNA, RNA content, etc. It is widely used in hematology, immunology, oncology, pharmacology, molecular biology, and other disciplines.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Flow Cytometry Testing Technology Service, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Flow Cytometry Testing Technology Service by region & country, by Type, and by Application.
The Flow Cytometry Testing Technology Service market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flow Cytometry Testing Technology Service.
Market Segmentation
By Company
Bioss
Q2 Solutions
KMD Bioscience
Thermo Fisher Scientific Inc
BD
Creative Bioarray
Labcorp
RayBiotech
Sysmex Corporation
Abace Biotechnology
Multi Sciences (Lianke) Biotech Co., Ltd
Shanghai Yingbai Biotechnology Co., Ltd
COBIOER BIOSCIENCES CO.,LTD
Shanghai Medicilon Inc
Beijing Nuowei Biotechnology Co., Ltd
Wuhan Servicebio Technology Co., Ltd
Segment by Type:
Analytical
Sorting Type
Segment by Application
Cell Cycle and Apoptosis Analysis
Immunological Analysis
Cell Typing Analysis
Other Fluorescence-Based Cytology Assays
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Flow Cytometry Testing Technology Service manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Flow Cytometry Testing Technology Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Flow Cytometry Testing Technology Service in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Flow Cytometry Testing Technology Service Product Introduction
1.2 Global Flow Cytometry Testing Technology Service Market Size Forecast
1.3 Flow Cytometry Testing Technology Service Market Trends & Drivers
1.3.1 Flow Cytometry Testing Technology Service Industry Trends
1.3.2 Flow Cytometry Testing Technology Service Market Drivers & Opportunity
1.3.3 Flow Cytometry Testing Technology Service Market Challenges
1.3.4 Flow Cytometry Testing Technology Service Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Flow Cytometry Testing Technology Service Players Revenue Ranking (2023)
2.2 Global Flow Cytometry Testing Technology Service Revenue by Company (2019-2024)
2.3 Key Companies Flow Cytometry Testing Technology Service Manufacturing Base Distribution and Headquarters
2.4 Key Companies Flow Cytometry Testing Technology Service Product Offered
2.5 Key Companies Time to Begin Mass Production of Flow Cytometry Testing Technology Service
2.6 Flow Cytometry Testing Technology Service Market Competitive Analysis
2.6.1 Flow Cytometry Testing Technology Service Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Flow Cytometry Testing Technology Service Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flow Cytometry Testing Technology Service as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Analytical
3.1.2 Sorting Type
3.2 Global Flow Cytometry Testing Technology Service Sales Value by Type
3.2.1 Global Flow Cytometry Testing Technology Service Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Flow Cytometry Testing Technology Service Sales Value, by Type (2019-2030)
3.2.3 Global Flow Cytometry Testing Technology Service Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Cell Cycle and Apoptosis Analysis
4.1.2 Immunological Analysis
4.1.3 Cell Typing Analysis
4.1.4 Other Fluorescence-Based Cytology Assays
4.2 Global Flow Cytometry Testing Technology Service Sales Value by Application
4.2.1 Global Flow Cytometry Testing Technology Service Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Flow Cytometry Testing Technology Service Sales Value, by Application (2019-2030)
4.2.3 Global Flow Cytometry Testing Technology Service Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Flow Cytometry Testing Technology Service Sales Value by Region
5.1.1 Global Flow Cytometry Testing Technology Service Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Flow Cytometry Testing Technology Service Sales Value by Region (2019-2024)
5.1.3 Global Flow Cytometry Testing Technology Service Sales Value by Region (2025-2030)
5.1.4 Global Flow Cytometry Testing Technology Service Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Flow Cytometry Testing Technology Service Sales Value, 2019-2030
5.2.2 North America Flow Cytometry Testing Technology Service Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Flow Cytometry Testing Technology Service Sales Value, 2019-2030
5.3.2 Europe Flow Cytometry Testing Technology Service Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Flow Cytometry Testing Technology Service Sales Value, 2019-2030
5.4.2 Asia Pacific Flow Cytometry Testing Technology Service Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Flow Cytometry Testing Technology Service Sales Value, 2019-2030
5.5.2 South America Flow Cytometry Testing Technology Service Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Flow Cytometry Testing Technology Service Sales Value, 2019-2030
5.6.2 Middle East & Africa Flow Cytometry Testing Technology Service Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Flow Cytometry Testing Technology Service Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Flow Cytometry Testing Technology Service Sales Value
6.3 United States
6.3.1 United States Flow Cytometry Testing Technology Service Sales Value, 2019-2030
6.3.2 United States Flow Cytometry Testing Technology Service Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Flow Cytometry Testing Technology Service Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Flow Cytometry Testing Technology Service Sales Value, 2019-2030
6.4.2 Europe Flow Cytometry Testing Technology Service Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Flow Cytometry Testing Technology Service Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Flow Cytometry Testing Technology Service Sales Value, 2019-2030
6.5.2 China Flow Cytometry Testing Technology Service Sales Value by Type (%), 2023 VS 2030
6.5.3 China Flow Cytometry Testing Technology Service Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Flow Cytometry Testing Technology Service Sales Value, 2019-2030
6.6.2 Japan Flow Cytometry Testing Technology Service Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Flow Cytometry Testing Technology Service Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Flow Cytometry Testing Technology Service Sales Value, 2019-2030
6.7.2 South Korea Flow Cytometry Testing Technology Service Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Flow Cytometry Testing Technology Service Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Flow Cytometry Testing Technology Service Sales Value, 2019-2030
6.8.2 Southeast Asia Flow Cytometry Testing Technology Service Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Flow Cytometry Testing Technology Service Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Flow Cytometry Testing Technology Service Sales Value, 2019-2030
6.9.2 India Flow Cytometry Testing Technology Service Sales Value by Type (%), 2023 VS 2030
6.9.3 India Flow Cytometry Testing Technology Service Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Bioss
7.1.1 Bioss Profile
7.1.2 Bioss Main Business
7.1.3 Bioss Flow Cytometry Testing Technology Service Products, Services and Solutions
7.1.4 Bioss Flow Cytometry Testing Technology Service Revenue (US$ Million) & (2019-2024)
7.1.5 Bioss Recent Developments
7.2 Q2 Solutions
7.2.1 Q2 Solutions Profile
7.2.2 Q2 Solutions Main Business
7.2.3 Q2 Solutions Flow Cytometry Testing Technology Service Products, Services and Solutions
7.2.4 Q2 Solutions Flow Cytometry Testing Technology Service Revenue (US$ Million) & (2019-2024)
7.2.5 Q2 Solutions Recent Developments
7.3 KMD Bioscience
7.3.1 KMD Bioscience Profile
7.3.2 KMD Bioscience Main Business
7.3.3 KMD Bioscience Flow Cytometry Testing Technology Service Products, Services and Solutions
7.3.4 KMD Bioscience Flow Cytometry Testing Technology Service Revenue (US$ Million) & (2019-2024)
7.3.5 Thermo Fisher Scientific Inc Recent Developments
7.4 Thermo Fisher Scientific Inc
7.4.1 Thermo Fisher Scientific Inc Profile
7.4.2 Thermo Fisher Scientific Inc Main Business
7.4.3 Thermo Fisher Scientific Inc Flow Cytometry Testing Technology Service Products, Services and Solutions
7.4.4 Thermo Fisher Scientific Inc Flow Cytometry Testing Technology Service Revenue (US$ Million) & (2019-2024)
7.4.5 Thermo Fisher Scientific Inc Recent Developments
7.5 BD
7.5.1 BD Profile
7.5.2 BD Main Business
7.5.3 BD Flow Cytometry Testing Technology Service Products, Services and Solutions
7.5.4 BD Flow Cytometry Testing Technology Service Revenue (US$ Million) & (2019-2024)
7.5.5 BD Recent Developments
7.6 Creative Bioarray
7.6.1 Creative Bioarray Profile
7.6.2 Creative Bioarray Main Business
7.6.3 Creative Bioarray Flow Cytometry Testing Technology Service Products, Services and Solutions
7.6.4 Creative Bioarray Flow Cytometry Testing Technology Service Revenue (US$ Million) & (2019-2024)
7.6.5 Creative Bioarray Recent Developments
7.7 Labcorp
7.7.1 Labcorp Profile
7.7.2 Labcorp Main Business
7.7.3 Labcorp Flow Cytometry Testing Technology Service Products, Services and Solutions
7.7.4 Labcorp Flow Cytometry Testing Technology Service Revenue (US$ Million) & (2019-2024)
7.7.5 Labcorp Recent Developments
7.8 RayBiotech
7.8.1 RayBiotech Profile
7.8.2 RayBiotech Main Business
7.8.3 RayBiotech Flow Cytometry Testing Technology Service Products, Services and Solutions
7.8.4 RayBiotech Flow Cytometry Testing Technology Service Revenue (US$ Million) & (2019-2024)
7.8.5 RayBiotech Recent Developments
7.9 Sysmex Corporation
7.9.1 Sysmex Corporation Profile
7.9.2 Sysmex Corporation Main Business
7.9.3 Sysmex Corporation Flow Cytometry Testing Technology Service Products, Services and Solutions
7.9.4 Sysmex Corporation Flow Cytometry Testing Technology Service Revenue (US$ Million) & (2019-2024)
7.9.5 Sysmex Corporation Recent Developments
7.10 Abace Biotechnology
7.10.1 Abace Biotechnology Profile
7.10.2 Abace Biotechnology Main Business
7.10.3 Abace Biotechnology Flow Cytometry Testing Technology Service Products, Services and Solutions
7.10.4 Abace Biotechnology Flow Cytometry Testing Technology Service Revenue (US$ Million) & (2019-2024)
7.10.5 Abace Biotechnology Recent Developments
7.11 Multi Sciences (Lianke) Biotech Co., Ltd
7.11.1 Multi Sciences (Lianke) Biotech Co., Ltd Profile
7.11.2 Multi Sciences (Lianke) Biotech Co., Ltd Main Business
7.11.3 Multi Sciences (Lianke) Biotech Co., Ltd Flow Cytometry Testing Technology Service Products, Services and Solutions
7.11.4 Multi Sciences (Lianke) Biotech Co., Ltd Flow Cytometry Testing Technology Service Revenue (US$ Million) & (2019-2024)
7.11.5 Multi Sciences (Lianke) Biotech Co., Ltd Recent Developments
7.12 Shanghai Yingbai Biotechnology Co., Ltd
7.12.1 Shanghai Yingbai Biotechnology Co., Ltd Profile
7.12.2 Shanghai Yingbai Biotechnology Co., Ltd Main Business
7.12.3 Shanghai Yingbai Biotechnology Co., Ltd Flow Cytometry Testing Technology Service Products, Services and Solutions
7.12.4 Shanghai Yingbai Biotechnology Co., Ltd Flow Cytometry Testing Technology Service Revenue (US$ Million) & (2019-2024)
7.12.5 Shanghai Yingbai Biotechnology Co., Ltd Recent Developments
7.13 COBIOER BIOSCIENCES CO.,LTD
7.13.1 COBIOER BIOSCIENCES CO.,LTD Profile
7.13.2 COBIOER BIOSCIENCES CO.,LTD Main Business
7.13.3 COBIOER BIOSCIENCES CO.,LTD Flow Cytometry Testing Technology Service Products, Services and Solutions
7.13.4 COBIOER BIOSCIENCES CO.,LTD Flow Cytometry Testing Technology Service Revenue (US$ Million) & (2019-2024)
7.13.5 COBIOER BIOSCIENCES CO.,LTD Recent Developments
7.14 Shanghai Medicilon Inc
7.14.1 Shanghai Medicilon Inc Profile
7.14.2 Shanghai Medicilon Inc Main Business
7.14.3 Shanghai Medicilon Inc Flow Cytometry Testing Technology Service Products, Services and Solutions
7.14.4 Shanghai Medicilon Inc Flow Cytometry Testing Technology Service Revenue (US$ Million) & (2019-2024)
7.14.5 Shanghai Medicilon Inc Recent Developments
7.15 Beijing Nuowei Biotechnology Co., Ltd
7.15.1 Beijing Nuowei Biotechnology Co., Ltd Profile
7.15.2 Beijing Nuowei Biotechnology Co., Ltd Main Business
7.15.3 Beijing Nuowei Biotechnology Co., Ltd Flow Cytometry Testing Technology Service Products, Services and Solutions
7.15.4 Beijing Nuowei Biotechnology Co., Ltd Flow Cytometry Testing Technology Service Revenue (US$ Million) & (2019-2024)
7.15.5 Beijing Nuowei Biotechnology Co., Ltd Recent Developments
7.16 Wuhan Servicebio Technology Co., Ltd
7.16.1 Wuhan Servicebio Technology Co., Ltd Profile
7.16.2 Wuhan Servicebio Technology Co., Ltd Main Business
7.16.3 Wuhan Servicebio Technology Co., Ltd Flow Cytometry Testing Technology Service Products, Services and Solutions
7.16.4 Wuhan Servicebio Technology Co., Ltd Flow Cytometry Testing Technology Service Revenue (US$ Million) & (2019-2024)
7.16.5 Wuhan Servicebio Technology Co., Ltd Recent Developments
8 Industry Chain Analysis
8.1 Flow Cytometry Testing Technology Service Industrial Chain
8.2 Flow Cytometry Testing Technology Service Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Flow Cytometry Testing Technology Service Sales Model
8.5.2 Sales Channel
8.5.3 Flow Cytometry Testing Technology Service Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Bioss
Q2 Solutions
KMD Bioscience
Thermo Fisher Scientific Inc
BD
Creative Bioarray
Labcorp
RayBiotech
Sysmex Corporation
Abace Biotechnology
Multi Sciences (Lianke) Biotech Co., Ltd
Shanghai Yingbai Biotechnology Co., Ltd
COBIOER BIOSCIENCES CO.,LTD
Shanghai Medicilon Inc
Beijing Nuowei Biotechnology Co., Ltd
Wuhan Servicebio Technology Co., Ltd
听
听
*If Applicable.
